Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANAB compared with ZYME: revenue, margins and what each company keeps, and the suppliers and customers both name
ANAB
Anaptysbio, Inc
Change
Mkt cap
Revenue
Revenue
ZYME
Zymeworks Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANAB
Anaptysbio, Inc
vs
ZYME
Zymeworks Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
ANAB
with
ZYME
Uncorrelated: r 0.23 · 499D.
Shared co-movers
2
with ANAB
with ZYME
NRIX
Nurix Therapeutics, Inc.
r 0.32
r 0.36
DNLI
Denali Therapeutics Inc.
r 0.28
r 0.37
ANAB, solid
ZYME, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ANAB
Anaptysbio, Inc
Change
47.31
▼
−2.01%
Mkt cap
$1.4B
Revenue
$26M
Q1 FY26
Revenue
$235M
FY25
ZYME
Zymeworks Inc.
Change
29.20
▲
+0.71%
Regular session
Nov 3 '26
Mkt cap
$2.1B
Revenue
$5M
Q2 FY26
Revenue
$106M
FY25
vs
Compare
Regular session
Nov 3 '26
ANAB
Anaptysbio, Inc
vs
ZYME
Zymeworks Inc.
47.31
▼
−2.01%
Price
29.20
▲
+0.71%
$1.4B
Mkt cap
$2.1B
Q1 FY26
$26M
Revenue
$5M
Q2 FY26
FY25
$235M
Revenue
$106M
FY25
Change
Change
ANAB
47.31
▼
−2.01%
vs
ZYME
29.20
▲
+0.71%
Regular session
Nov 3 '26